Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design.

Area of Science:

• Molecular biology
• Virology
• Structural biology

Background:

• SARS-CoV-2 RNA helicase (NSP13) is crucial for viral replication and a key drug target.
• NSP13 is highly conserved across the Coronaviridae family, making it a promising therapeutic target.

Purpose of the Study:

• To model and analyze the structural dynamics of SARS-CoV-2 RNA helicase (NSP13) with its native substrates.
• To provide atomic-level insights into ATP and ssRNA binding and enzyme motion.
• To identify potential allosteric binding sites for inhibitor development.

Main Methods:

• Analysis of homologous sequences and existing experimental structures.
• Microsecond-scale molecular dynamics (MD) simulations.
• Computational pocket analysis to identify allosteric sites.

Main Results:

• Detailed structural models and dynamics of NSP13 in complex with ATP and ssRNA.
• Identification of key enzyme motions influenced by substrate binding.
• Characterization of potential allosteric binding pockets.

Conclusions:

• The study provides critical structural and dynamic insights into SARS-CoV-2 NSP13.
• Findings support further investigation of catalytic mechanisms and inhibitor design.
• Identified binding pockets offer opportunities for developing specific COVID-19 therapeutics.